The compensation of Hanmi over violating the patent is judged to be KRW 10 million… “Got a minute to breath”
The court ruled Hanmi Pharm, which violated the patent related to the schizophrenia treatment, Zyprexa, to compensate KRW 10 million.
Since it was a judgment which did not accept the damage caused by the price reduction of the original product, it is analyzed that Hanmi Pharm has practically won...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
